Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMID 15134871)

Published in Peptides on March 01, 2004

Authors

Randal A Skidgel1, Ervin G Erdös

Author Affiliations

1: Department of Pharmacology, University of Illinois College of Medicine, Pharmacology (MC 868), 835 S. Wolcott Avenue, Chicago, IL 60612-7344, USA.

Articles citing this

Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain. Nat Rev Drug Discov (2012) 0.99

Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease. J Neurosci (2009) 0.98

Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats. Eur J Pharmacol (2010) 0.95

Kinin danger signals proteolytically released by gingipain induce Fimbriae-specific IFN-gamma- and IL-17-producing T cells in mice infected intramucosally with Porphyromonas gingivalis. J Immunol (2009) 0.94

Perspectives on the Trypanosoma cruzi-host cell receptor interactions. Parasitol Res (2009) 0.92

Kallikrein activates bradykinin B2 receptors in absence of kininogen. Am J Physiol Heart Circ Physiol (2005) 0.89

Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells. Clin Exp Immunol (2010) 0.87

A neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis. J Biol Chem (2014) 0.87

Extracellular biotransformation of beta-endorphin in rat striatum and cerebrospinal fluid. J Neuroendocrinol (2008) 0.86

The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humans. Psychiatry Res (2010) 0.86

The kallikrein-kinin system in experimental Chagas disease: a paradigm to investigate the impact of inflammatory edema on GPCR-mediated pathways of host cell invasion by Trypanosoma cruzi. Front Immunol (2013) 0.86

Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors. Hypertension (2005) 0.83

The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis. Cell Cycle (2011) 0.81

Circulating proteolytic products of carboxypeptidase N for early detection of breast cancer. Clin Chem (2013) 0.79

Multiple roles of angiotensin in colorectal cancer. World J Clin Oncol (2012) 0.79

Rhinorrhea, cough and fatigue in patients taking sitagliptin. Allergy Asthma Clin Immunol (2010) 0.78

Pharmacologic Comparison of Clinical Neutral Endopeptidase Inhibitors in a Rat Model of Acute Secretory Diarrhea. J Pharmacol Exp Ther (2016) 0.77

Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial. Eur J Clin Pharmacol (2016) 0.75

Long-term neprilysin inhibition - implications for ARNIs. Nat Rev Cardiol (2016) 0.75

Endothelial Nitric Oxide Synthase and Angiotensin Converting Enzyme Gene Polymorphisms in Migraine Patients. Noro Psikiyatr Ars (2013) 0.75

Endogenous opioids regulate moment-to-moment neuronal communication and excitability. Nat Commun (2017) 0.75

The Role of Neutrophil Proteins on the Amyloid Beta-RAGE Axis. PLoS One (2016) 0.75

Neuropeptide Levels as well as Neprilysin Activity Decrease in Renal Cell Carcinoma. Cancer Microenviron (2016) 0.75

Angiotensin-converting enzyme gene insertion/deletion polymorphism in nutritional disorders in children. Eur J Nutr (2014) 0.75

Articles by these authors

Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands. Mol Pharmacol (2004) 1.09

The discovery of captopril: reply. FASEB J (2004) 1.08

Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator. Int Immunopharmacol (2007) 1.05

Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor. J Biol Chem (2002) 1.02

Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A. Hypertension (2002) 1.00

Kinins, the long march--a personal view. Cardiovasc Res (2002) 0.93

Human ACE and bradykinin B2 receptors form a complex at the plasma membrane. FASEB J (2006) 0.93

Kallikrein activates bradykinin B2 receptors in absence of kininogen. Am J Physiol Heart Circ Physiol (2005) 0.89

Activation of bradykinin B1 receptor by ACE inhibitors. Int Immunopharmacol (2002) 0.89

Kinin- and angiotensin-converting enzyme (ACE) inhibitor-mediated nitric oxide production in endothelial cells. Biol Chem (2006) 0.84

Angiotensin I-converting enzyme inhibitors block protein kinase C epsilon by activating bradykinin B1 receptors in human endothelial cells. J Pharmacol Exp Ther (2005) 0.84

Positive cooperativity between the thrombin and bradykinin B2 receptors enhances arachidonic acid release. Am J Physiol Heart Circ Physiol (2005) 0.83

Neprilysin inhibitors potentiate effects of bradykinin on b2 receptor. Hypertension (2002) 0.83

Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors. Hypertension (2005) 0.83

Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain. J Mol Biol (2006) 0.83

Kallikreins when activating bradykinin B2 receptor induce its redistribution on plasma membrane. Int Immunopharmacol (2002) 0.82

Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N. Biochem J (2005) 0.76

Regarding "German science and black racism--roots of the Nazi Holocaust". FASEB J (2008) 0.75

B2R of bradykinin activated by proteases. Hypertension (2003) 0.75